Jefferies Financial Group Inc. Acquires Shares of 10,493 Silicon Laboratories Inc. (NASDAQ:SLAB)

Jefferies Financial Group Inc. acquired a new stake in shares of Silicon Laboratories Inc. (NASDAQ:SLAB - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The fund acquired 10,493 shares of the semiconductor company's stock, valued at approximately $1,303,000.

Several other large investors have also bought and sold shares of SLAB. Capital Research Global Investors boosted its position in Silicon Laboratories by 23.3% during the 4th quarter. Capital Research Global Investors now owns 2,131,920 shares of the semiconductor company's stock valued at $264,827,000 after acquiring an additional 403,010 shares in the last quarter. Norges Bank purchased a new position in shares of Silicon Laboratories during the fourth quarter valued at approximately $34,622,000. Invesco Ltd. lifted its holdings in shares of Silicon Laboratories by 46.9% during the fourth quarter. Invesco Ltd. now owns 595,382 shares of the semiconductor company's stock valued at $73,958,000 after purchasing an additional 190,085 shares during the last quarter. Raymond James Financial Inc. purchased a new position in shares of Silicon Laboratories during the fourth quarter valued at approximately $14,252,000. Finally, Alliancebernstein L.P. lifted its holdings in shares of Silicon Laboratories by 58.2% during the fourth quarter. Alliancebernstein L.P. now owns 240,321 shares of the semiconductor company's stock valued at $29,853,000 after purchasing an additional 88,438 shares during the last quarter.

Insider Transactions at Silicon Laboratories

In other Silicon Laboratories news, Director Christy Wyatt sold 546 shares of the stock in a transaction on Tuesday, May 6th. The stock was sold at an average price of $104.45, for a total value of $57,029.70. Following the completion of the sale, the director now owns 8,492 shares in the company, valued at approximately $886,989.40. This represents a 6.04% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Robert Matthew Johnson sold 5,879 shares of the stock in a transaction on Friday, May 16th. The stock was sold at an average price of $131.20, for a total value of $771,324.80. Following the completion of the sale, the chief executive officer now owns 73,688 shares of the company's stock, valued at $9,667,865.60. The trade was a 7.39% decrease in their position. The disclosure for this sale can be found here. Insiders sold 11,626 shares of company stock worth $1,509,319 in the last three months. Corporate insiders own 1.60% of the company's stock.

Silicon Laboratories Stock Performance

Shares of NASDAQ SLAB traded down $3.75 during midday trading on Friday, hitting $120.03. 298,144 shares of the stock traded hands, compared to its average volume of 337,954. The firm has a 50-day moving average of $108.69 and a two-hundred day moving average of $122.08. The firm has a market capitalization of $3.91 billion, a P/E ratio of -20.21 and a beta of 1.36. Silicon Laboratories Inc. has a one year low of $82.82 and a one year high of $160.00.

Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last posted its quarterly earnings data on Tuesday, May 13th. The semiconductor company reported ($0.08) EPS for the quarter, topping the consensus estimate of ($0.09) by $0.01. The firm had revenue of $177.71 million during the quarter, compared to analyst estimates of $177.48 million. Silicon Laboratories had a negative return on equity of 10.46% and a negative net margin of 32.69%. Silicon Laboratories's revenue was up 67.0% on a year-over-year basis. During the same period in the prior year, the business posted ($0.92) EPS. Equities analysts forecast that Silicon Laboratories Inc. will post -0.97 earnings per share for the current fiscal year.

Analysts Set New Price Targets

SLAB has been the subject of several recent research reports. Wall Street Zen upgraded shares of Silicon Laboratories from a "sell" rating to a "hold" rating in a report on Wednesday, May 14th. Barclays decreased their price objective on shares of Silicon Laboratories from $120.00 to $80.00 and set an "equal weight" rating for the company in a report on Tuesday, April 22nd. Susquehanna boosted their price objective on shares of Silicon Laboratories from $100.00 to $110.00 and gave the stock a "neutral" rating in a report on Wednesday, May 14th. Benchmark restated a "buy" rating and issued a $160.00 price objective on shares of Silicon Laboratories in a report on Tuesday. Finally, Stifel Nicolaus decreased their price objective on shares of Silicon Laboratories from $145.00 to $120.00 and set a "buy" rating for the company in a report on Thursday, April 17th. Four investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company's stock. Based on data from MarketBeat, Silicon Laboratories has an average rating of "Moderate Buy" and a consensus price target of $126.50.

Silicon Laboratories Company Profile

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.